
|Articles|November 6, 2020
Assessing Multiple Critical Quality Attributes of Monoclonal Antibody and Comparability Assessments
Author(s)Agilent Technologies, Inc.
Discover how LC–MS peptide mapping can be used to characterize and quantify different monoclonal antibody (mAb) critical quality attributes (CQAs).
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Best of the Week: Profiling Endoenous Protein Complexes, Previewing Riva 2026
2
Riva Returns Alive and Kicking
3
Exercise-Induced Gut-Brain Axis Modulation in Autism: Insights from Chromatographic Metabolite Analysis
4
Restek Introduces GC Columns Featuring TriMax Technology for Trace-level Sensitivity
5